Edwards Lifesciences Research and Development Expenses 2010-2024 | EW
Edwards Lifesciences annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Edwards Lifesciences research and development expenses for the quarter ending March 31, 2024 were $0.285B, a 9.19% increase year-over-year.
- Edwards Lifesciences research and development expenses for the twelve months ending March 31, 2024 were $1.096B, a 12.07% increase year-over-year.
- Edwards Lifesciences annual research and development expenses for 2023 were $1.072B, a 13.39% increase from 2022.
- Edwards Lifesciences annual research and development expenses for 2022 were $0.945B, a 4.66% increase from 2021.
- Edwards Lifesciences annual research and development expenses for 2021 were $0.903B, a 18.72% increase from 2020.
| Edwards Lifesciences Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $1,072 |
| 2022 | $945 |
| 2021 | $903 |
| 2020 | $761 |
| 2019 | $753 |
| 2018 | $622 |
| 2017 | $553 |
| 2016 | $442 |
| 2015 | $383 |
| 2014 | $347 |
| 2013 | $323 |
| 2012 | $291 |
| 2011 | $246 |
| 2010 | $204 |
| 2009 | $176 |
| Edwards Lifesciences Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $285 |
| 2023-12-31 | $270 |
| 2023-09-30 | $270 |
| 2023-06-30 | $270 |
| 2023-03-31 | $261 |
| 2022-12-31 | $232 |
| 2022-09-30 | $234 |
| 2022-06-30 | $251 |
| 2022-03-31 | $229 |
| 2021-12-31 | $233 |
| 2021-09-30 | $238 |
| 2021-06-30 | $225 |
| 2021-03-31 | $207 |
| 2020-12-31 | $196 |
| 2020-09-30 | $196 |
| 2020-06-30 | $182 |
| 2020-03-31 | $187 |
| 2019-12-31 | $194 |
| 2019-09-30 | $196 |
| 2019-06-30 | $192 |
| 2019-03-31 | $171 |
| 2018-12-31 | $163 |
| 2018-09-30 | $162 |
| 2018-06-30 | $154 |
| 2018-03-31 | $143 |
| 2017-12-31 | $147 |
| 2017-09-30 | $143 |
| 2017-06-30 | $134 |
| 2017-03-31 | $129 |
| 2016-12-31 | $115 |
| 2016-09-30 | $113 |
| 2016-06-30 | $113 |
| 2016-03-31 | $102 |
| 2015-12-31 | $98 |
| 2015-09-30 | $101 |
| 2015-06-30 | $98 |
| 2015-03-31 | $86 |
| 2014-12-31 | $84 |
| 2014-09-30 | $88 |
| 2014-06-30 | $89 |
| 2014-03-31 | $86 |
| 2013-12-31 | $79 |
| 2013-09-30 | $84 |
| 2013-06-30 | $81 |
| 2013-03-31 | $80 |
| 2012-12-31 | $75 |
| 2012-09-30 | $74 |
| 2012-06-30 | $74 |
| 2012-03-31 | $69 |
| 2011-12-31 | $61 |
| 2011-09-30 | $62 |
| 2011-06-30 | $65 |
| 2011-03-31 | $59 |
| 2010-12-31 | $56 |
| 2010-09-30 | $53 |
| 2010-06-30 | $51 |
| 2010-03-31 | $45 |
| 2009-12-31 | $88 |
| 2009-09-30 | $45 |
| 2009-06-30 | $43 |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $53.716B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $227.236B | 27.53 |
| Intuitive Surgical (ISRG) | United States | $141.461B | 85.22 |
| DexCom (DXCM) | United States | $52.240B | 79.13 |
| IDEXX Laboratories (IDXX) | United States | $44.882B | 52.61 |
| Alcon (ALC) | Switzerland | $43.802B | 31.39 |
| IQVIA Holdings (IQV) | United States | $42.121B | 24.44 |
| STERIS (STE) | Ireland | $22.993B | 26.87 |
| Waters (WAT) | United States | $21.115B | 31.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $17.508B | 19.59 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.893B | 15.05 |
| ShockWave Medical (SWAV) | United States | $12.394B | 77.13 |
| Sysmex ADR (SSMXY) | Japan | $11.077B | 34.74 |
| Teleflex (TFX) | United States | $10.251B | 15.96 |
| Globus Medical (GMED) | United States | $8.718B | 25.56 |
| Penumbra (PEN) | United States | $7.890B | 89.66 |
| Masimo (MASI) | United States | $6.588B | 37.95 |
| Glaukos (GKOS) | United States | $5.530B | 0.00 |
| TransMedics (TMDX) | United States | $4.545B | 431.19 |
| Integer Holdings (ITGR) | United States | $4.051B | 24.48 |
| PROCEPT BioRobotics (PRCT) | United States | $3.502B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.355B | 19.92 |
| Tandem Diabetes Care (TNDM) | United States | $3.055B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.926B | 20.07 |
| Inari Medical (NARI) | United States | $2.660B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.485B | 21.02 |
| RxSight (RXST) | United States | $2.243B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.170B | 9.46 |
| Veracyte (VCYT) | United States | $1.749B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.546B | 0.00 |
| Artivion (AORT) | United States | $0.978B | 93.84 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.936B | 18.20 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.875B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.763B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.659B | 22.39 |
| Paragon 28 (FNA) | United States | $0.635B | 0.00 |
| SiBone (SIBN) | United States | $0.615B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.563B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.550B | 0.00 |
| IRadimed (IRMD) | United States | $0.532B | 29.81 |
| Pulse Biosciences (PLSE) | United States | $0.431B | 0.00 |
| Nevro (NVRO) | United States | $0.419B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.326B | 11.16 |
| Treace Medical Concepts (TMCI) | United States | $0.310B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| AxoGen (AXGN) | United States | $0.264B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.249B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| NeuroPace (NPCE) | United States | $0.235B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.197B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.170B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.163B | 8.25 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.108B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.097B | 20.45 |
| Yubo Biotech (YBGJ) | China | $0.095B | 0.00 |
| Neuronetics (STIM) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.057B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.033B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.031B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.029B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |